We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.56%
4 Consumer Discretionary 5.98%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMG icon
201
Warner Music
WMG
$13.1B
$19.8M 0.09%
644,386
+99,386
+18% +$3.04M
FDS icon
202
Factset
FDS
$9.59B
$19.6M 0.09%
67,589
+66,638
+7,007% +$18.7M
CTAS icon
203
Cintas
CTAS
$81.6B
$19.6M 0.09%
104,237
+50,256
+93% +$9.47M
NSA
204
DELISTED
National Storage Affiliates Trust
NSA
$19.4M 0.09%
688,670
-378,878
-35% -$11.3M
JBL icon
205
Jabil
JBL
$33.4B
$19.3M 0.09%
84,608
+72,455
+596% +$15.5M
AMP icon
206
Ameriprise Financial
AMP
$48.8B
$19.2M 0.09%
39,254
-14,496
-27% -$6.88M
UNM icon
207
Unum
UNM
$14.3B
$19.1M 0.08%
246,048
+100,831
+69% +$7.71M
SNAP icon
208
Snap
SNAP
$8.48B
$19.1M 0.08%
2,362,132
+1,473,288
+166% +$11.7M
ATMU icon
209
Atmus Filtration Technologies
ATMU
$4.4B
$19M 0.08%
+366,118
New +$17.7M
NAVN
210
Navan Inc
NAVN
$6.99B
$19M 0.08%
+1,111,263
New +$17.7M
AXS icon
211
AXIS Capital
AXS
$7.72B
$19M 0.08%
177,078
+148,468
+519% +$14.7M
BIIB icon
212
Biogen
BIIB
$29.8B
$18.8M 0.08%
107,068
-213,086
-67% -$34.8M
GOOGL icon
213
CALL
Alphabet (Google) Class A
GOOGL
$4.57T
$18.3M 0.08%
58,500
-20,000
-25% -$5.71M
EVR icon
214
Evercore
EVR
$12.3B
$18.3M 0.08%
53,638
+46,381
+639% +$14.9M
ASH icon
215
Ashland
ASH
$3.29B
$18.2M 0.08%
310,677
+305,876
+6,371% +$16.2M
MKTX icon
216
MarketAxess Holdings
MKTX
$5.71B
$18.2M 0.08%
100,235
-19,926
-17% -$3.4M
BHVN icon
217
Biohaven
BHVN
$2.01B
$18.1M 0.08%
1,606,777
+1,565,891
+3,830% +$19.4M
ESAB icon
218
ESAB
ESAB
$5.66B
$17.9M 0.08%
160,239
-135,506
-46% -$15.5M
FCX icon
219
CALL
Freeport-McMoran
FCX
$91.5B
$17.9M 0.08%
352,100
-767,300
-69% -$33.3M
ALNY icon
220
Alnylam Pharmaceuticals
ALNY
$29.5B
$17.9M 0.08%
44,894
+35,185
+362% +$15.6M
GL icon
221
Globe Life
GL
$14.3B
$17.9M 0.08%
127,638
+122,909
+2,599% +$16.6M
IRM icon
222
Iron Mountain
IRM
$36.9B
$17.4M 0.08%
209,300
+111,071
+113% +$10.4M
CRDO icon
223
Credo Technology Group
CRDO
$40.7B
$17.4M 0.08%
120,605
+76,887
+176% +$11.8M
CF icon
224
CF Industries
CF
$18.2B
$17.3M 0.08%
+223,356
New +$18.4M
CME icon
225
CME Group
CME
$95.7B
$17.3M 0.08%
63,199
+60,033
+1,896% +$16.3M

Similar funds

Schonfeld Strategic Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Schonfeld Strategic Advisors held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schonfeld Strategic Advisors deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Schonfeld Strategic Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Schonfeld Strategic Advisors fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Schonfeld Strategic Advisors opened 620 new positions and closed 789 in Q4 2025.
  • Schonfeld Strategic Advisors's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.